# PET Detection of CCR2 in Human Atherosclerosis

> **NCT04537403** · PHASE1 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 100 (estimated)

## Conditions studied

- Carotid Atherosclerosis

## Interventions

- **DRUG:** Group 1-64CU-DOTA-ECL1i (radioactive imaging medicine)
- **DRUG:** Group 2 64CU-DOTA-ECL1i (radioactive imaging medicine)

## Key facts

- **NCT ID:** NCT04537403
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-01
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-09-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04537403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04537403, "PET Detection of CCR2 in Human Atherosclerosis". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT04537403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*